BI 1819479
BI 1819479 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 83.3%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
83.3%
5 of 6 finished
16.7%
1 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Test How BI 1819479 is Taken up and Processed by the Body
A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
A Study to Test How Healthy Women Tolerate Different Doses of BI 1819479
A Study in Healthy Men to Test How Well Different Doses of BI 1819479 Are Tolerated
A Study in Healthy Men to Test How Esomeprazole Influences the Amount of BI 1819479 in the Blood
Clinical Trials (6)
A Study to Test How BI 1819479 is Taken up and Processed by the Body
A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
A Study to Test How Healthy Women Tolerate Different Doses of BI 1819479
A Study in Healthy Men to Test How Well Different Doses of BI 1819479 Are Tolerated
A Study in Healthy Men to Test How Esomeprazole Influences the Amount of BI 1819479 in the Blood
A Study in Healthy Men to Test How Well Different Doses of BI 1819479 Are Tolerated and Taken up by the Body With or Without Food
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6